CHEMOMAB THERAPEUTICS ANNOUNCES LATE-BREAKING ORAL PRESENTATION OF CM-101 PHASE 2 RESULTS IN PRIMARY SCLEROSING CHOLANGITIS AT AASLD THE LIVER MEETING® 2024

Reuters · 10/15 11:00

Please log in to view news